MediciNova, Inc.
(NASDAQ : MNOV)

( )
MNOV After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. -0.94%240.321.3%$846.08m
MRNAModerna, Inc. -2.96%65.170.0%$695.63m
IMMUImmunomedics, Inc. 0.15%85.3011.0%$670.56m
NVAXNovavax, Inc. 0.86%102.4496.5%$610.34m
GILDGilead Sciences, Inc. -1.33%62.251.0%$565.51m
ILMNIllumina, Inc. 4.88%286.313.5%$473.05m
REGNRegeneron Pharmaceuticals, Inc. -1.37%557.462.7%$432.62m
BIIBBiogen, Inc. -0.79%270.041.6%$334.79m
VRTXVertex Pharmaceuticals, Inc. -0.26%263.131.9%$321.06m
ALXNAlexion Pharmaceuticals, Inc. -0.37%112.022.0%$277.96m
SRNESorrento Therapeutics, Inc. -4.27%9.191.5%$257.41m
MNTAMomenta Pharmaceuticals, Inc. 0.19%52.393.0%$205.44m
SGENSeattle Genetics, Inc. 0.09%179.436.0%$202.59m
VXRTVaxart, Inc. -4.17%6.890.0%$195.90m
BMRNBioMarin Pharmaceutical, Inc. -2.36%76.584.3%$192.95m

Company Profile

MediciNova, Inc. is a biopharmaceutical company, which engages in the acquisition and development of small molecule therapeutics for the treatment of serious diseases for the treatment of diseases with unmet medical need. Its development pipeline consists of clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.